Literature DB >> 8811366

Tick factors and in vitro cultivation influence the protein profile, antigenicity and pathogenicity of a cloned Borrelia garinii isolate from Ixodes ricinus hemolymph.

C M Hu1, M Simon, M D Kramer, L Gern.   

Abstract

A Borrelia garinii isolate (NE11H) was obtained from the hemolymph of infed Ixodes ricinus. NE11H expressed four major proteins of 33 kDa, 32 kDa, 23 kDa and 22 kDa. During in vitro culture, NE11H successively lost the expression of the 22 kDa and 23 kDa proteins and the NE11H variant (NE11Hp15) was not recognized by an immune serum specific for the OspC protein (anti-OspC IS). However, when reintroduced into tick midguts, NE11Hp15 spirochetes present in the midgut again reacted with anti-OspC IS. A clone derived from the wild type line, cNE11H, lacked the 22 kDa but not the 23 kDa protein. The 23 kDa protein of cNE11H was recognized by anti-OspC IS. In addition, the two descendant lines (NE11Hp15 and cNE11H) lost their capacity to induce clinical arthritis in SCID mice. When cNE11H was reintroduced into ticks and reisolated from various tick organs, most reisolates presented the same reaction with anti-OspC IS as cNE11H. Interestingly, two reisolates obtained from the tick midgut reexpressed large amounts of the 22 kDa protein which was recognized by anti-OspC IS and these two reisolates induced clinical arthritis in SCID mice. The results confirm that proteins of 22/23 kDa are differentially expressed during in vitro subcultures and in ticks, and show that proteins which are not detectable after in vitro culture may be reexpressed after reexposure of B. burgdorferi to its former environment in the tick. The data suggest that the pathogenicity of B. burgdorferi for mice might be influenced by environmental factors via differential expression of 22/23 kDa proteins.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8811366     DOI: 10.1007/bf01781105

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  28 in total

1.  Polymorphisms of major surface proteins of Borrelia burgdorferi.

Authors:  A G Barbour; M E Schrumpf
Journal:  Zentralbl Bakteriol Mikrobiol Hyg A       Date:  1986-12

2.  Antigenic variability of Borrelia burgdorferi.

Authors:  B Wilske; V Preac-Mursic; G Schierz; R Kühbeck; A G Barbour; M Kramer
Journal:  Ann N Y Acad Sci       Date:  1988       Impact factor: 5.691

3.  Dissemination and salivary delivery of Lyme disease spirochetes in vector ticks (Acari: Ixodidae).

Authors:  J M Ribeiro; T N Mather; J Piesman; A Spielman
Journal:  J Med Entomol       Date:  1987-03       Impact factor: 2.278

4.  Lyme borreliosis in the severe combined immunodeficiency (scid) mouse manifests predominantly in the joints, heart, and liver.

Authors:  U E Schaible; S Gay; C Museteanu; M D Kramer; G Zimmer; K Eichmann; U Museteanu; M M Simon
Journal:  Am J Pathol       Date:  1990-10       Impact factor: 4.307

5.  Lyme borreliosis in laboratory animals: effect of host species and in vitro passage of Borrelia burgdorferi.

Authors:  K D Moody; S W Barthold; G A Terwilliger
Journal:  Am J Trop Med Hyg       Date:  1990-07       Impact factor: 2.345

6.  Clonal polymorphisms of outer membrane protein OspB of Borrelia burgdorferi.

Authors:  V G Bundoc; A G Barbour
Journal:  Infect Immun       Date:  1989-09       Impact factor: 3.441

7.  Distribution and molecular analysis of Lyme disease spirochetes, Borrelia burgdorferi, isolated from ticks throughout California.

Authors:  T G Schwan; M E Schrumpf; R H Karstens; J R Clover; J Wong; M Daugherty; M Struthers; P A Rosa
Journal:  J Clin Microbiol       Date:  1993-12       Impact factor: 5.948

8.  Mode of inoculation of the Lyme disease agent Borrelia burgdorferi influences infection and immune responses in inbred strains of mice.

Authors:  L Gern; U E Schaible; M M Simon
Journal:  J Infect Dis       Date:  1993-04       Impact factor: 5.226

9.  Immunological and molecular polymorphisms of OspC, an immunodominant major outer surface protein of Borrelia burgdorferi.

Authors:  B Wilske; V Preac-Mursic; S Jauris; A Hofmann; I Pradel; E Soutschek; E Schwab; G Will; G Wanner
Journal:  Infect Immun       Date:  1993-05       Impact factor: 3.441

10.  Isolation and cultivation of Lyme disease spirochetes.

Authors:  A G Barbour
Journal:  Yale J Biol Med       Date:  1984 Jul-Aug
View more
  6 in total

1.  Temporal changes in outer surface proteins A and C of the lyme disease-associated spirochete, Borrelia burgdorferi, during the chain of infection in ticks and mice.

Authors:  T G Schwan; J Piesman
Journal:  J Clin Microbiol       Date:  2000-01       Impact factor: 5.948

2.  Dynamics of dissemination and outer surface protein expression of different European Borrelia burgdorferi sensu lato strains in artificially infected Ixodes ricinus nymphs.

Authors:  Volker Fingerle; Sandra Rauser; Bettina Hammer; Olaf Kahl; Christiane Heimerl; Ulrike Schulte-Spechtel; Lise Gern; Bettina Wilske
Journal:  J Clin Microbiol       Date:  2002-04       Impact factor: 5.948

3.  Experimental inoculation with human granulocytic Ehrlichia agent derived from high- and low-passage cell culture in horses.

Authors:  N Pusterla; J E Madigan; K M Asanovich; J S Chae; E Derock; C M Leutenegger; J B Pusterla; H Lutz; J S Dumler
Journal:  J Clin Microbiol       Date:  2000-03       Impact factor: 5.948

4.  Further characterization of complement regulator-acquiring surface proteins of Borrelia burgdorferi.

Authors:  P Kraiczy; C Skerka; V Brade; P F Zipfel
Journal:  Infect Immun       Date:  2001-12       Impact factor: 3.441

5.  Experimental infection of dogs with Borrelia burgdorferi sensu stricto using Ixodes scapularis ticks artificially infected by capillary feeding.

Authors:  Jon B Korshus; Ulrike G Munderloh; Russell F Bey; Timothy J Kurtti
Journal:  Med Microbiol Immunol       Date:  2003-07-22       Impact factor: 3.402

6.  Borrelia burgdorferi population kinetics and selected gene expression at the host-vector interface.

Authors:  Emir Hodzic; Sunlian Feng; Kimberly J Freet; Dori L Borjesson; Stephen W Barthold
Journal:  Infect Immun       Date:  2002-07       Impact factor: 3.441

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.